Trials / Withdrawn
WithdrawnNCT02590497
Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
The Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Ohio State University Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This pilot clinical trial studies the correlation between the genetics and brain images of patients with newly diagnosed glioblastoma before surgery. The genetic characteristics of a tumor are an important way to predict how well it will respond to treatment. Imaging, using magnetic resonance imaging (MRI), takes detailed pictures of organs inside the body, and may also provide information that helps doctors predict how brain tumors will respond to treatment. If MRI can provide doctors with similar information about the tumor as the tumor's genes, it may be able to be used to predict tumor response in patients whose tumors cannot be reached by surgery or biopsy to get tissue samples.
Detailed description
PRIMARY OBJECTIVES: I. Determine the correlation between the genetic and neuroimaging signature of glioblastoma. II. Determine the correlation between the neuroimaging signature of glioblastoma and prognosis. OUTLINE: Patients undergo MRI before and after gadolinium contrast administration, including 3-dimensional (3D) volumetric T1-weighted sequence, fluid attenuated inversion recovery (FLAIR) sequence, diffusion weighted imaging, and perfusion MRI. Tissue samples are also analyzed for the tumor genetic profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Diffusion Weighted Imaging | Undergo diffusion weighted MRI |
| DRUG | Gadolinium | Undergo gadolinium-enhanced MRI |
| OTHER | Laboratory Biomarker Analysis | Tissue genetic analysis |
| PROCEDURE | Magnetic Resonance Imaging | Undergo gadolinium-enhanced MRI |
| PROCEDURE | Magnetic Resonance Imaging | Undergo 3D volumetric T1-weighted sequence |
| PROCEDURE | Magnetic Resonance Imaging | Undergo FLAIR sequence |
| PROCEDURE | Perfusion Magnetic Resonance Imaging | Undergo perfusion MRI |
Timeline
- Start date
- 2016-03-20
- Primary completion
- 2017-10-26
- Completion
- 2017-10-26
- First posted
- 2015-10-29
- Last updated
- 2018-01-31
Source: ClinicalTrials.gov record NCT02590497. Inclusion in this directory is not an endorsement.